Darji is conducting research about layer-by-layer elastin-like polypeptide nucleic acid nanoparticle (LENN), providing an alternative to current lipid nanoparticle delivery systems which must be stored as liquids below minus 45 degrees Celsius. The primary goal of this technology is targeted delivery of genetic material to cancer cells, with current work on bladder cancer. The platform is designed to achieve high specificity, unintended side effects.